1. Home
  2. VNDA vs CMCM Comparison

VNDA vs CMCM Comparison

Compare VNDA & CMCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • CMCM
  • Stock Information
  • Founded
  • VNDA 2002
  • CMCM 2009
  • Country
  • VNDA United States
  • CMCM China
  • Employees
  • VNDA N/A
  • CMCM N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • CMCM Computer Software: Prepackaged Software
  • Sector
  • VNDA Health Care
  • CMCM Technology
  • Exchange
  • VNDA Nasdaq
  • CMCM Nasdaq
  • Market Cap
  • VNDA 249.4M
  • CMCM 222.8M
  • IPO Year
  • VNDA 2006
  • CMCM 2014
  • Fundamental
  • Price
  • VNDA $4.41
  • CMCM $7.49
  • Analyst Decision
  • VNDA Strong Buy
  • CMCM
  • Analyst Count
  • VNDA 3
  • CMCM 0
  • Target Price
  • VNDA $14.00
  • CMCM N/A
  • AVG Volume (30 Days)
  • VNDA 682.0K
  • CMCM 43.9K
  • Earning Date
  • VNDA 10-29-2025
  • CMCM 12-16-2025
  • Dividend Yield
  • VNDA N/A
  • CMCM N/A
  • EPS Growth
  • VNDA N/A
  • CMCM N/A
  • EPS
  • VNDA N/A
  • CMCM N/A
  • Revenue
  • VNDA $212,074,000.00
  • CMCM $137,272,956.00
  • Revenue This Year
  • VNDA $14.32
  • CMCM $14.27
  • Revenue Next Year
  • VNDA $37.05
  • CMCM $39.26
  • P/E Ratio
  • VNDA N/A
  • CMCM N/A
  • Revenue Growth
  • VNDA 11.12
  • CMCM 38.54
  • 52 Week Low
  • VNDA $3.81
  • CMCM $3.28
  • 52 Week High
  • VNDA $5.70
  • CMCM $9.44
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 34.91
  • CMCM 49.23
  • Support Level
  • VNDA $4.32
  • CMCM $7.10
  • Resistance Level
  • VNDA $4.51
  • CMCM $7.80
  • Average True Range (ATR)
  • VNDA 0.23
  • CMCM 0.39
  • MACD
  • VNDA -0.13
  • CMCM -0.02
  • Stochastic Oscillator
  • VNDA 9.44
  • CMCM 65.62

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

Share on Social Networks: